Ducray

Ducray is a French dermatological skincare and haircare brand, owned since 1969 by the Pierre Fabre Group [5]. It built its reputation on products for the scalp and skin — treatments for hair loss, dandruff, acne, eczema and similar conditions — sold mainly through pharmacies and positioned as prescribed by dermatologists and recommended by pharmacists. The company traces its origins to Paris around 1930, when a young hairdresser, Albert Ducray, began making single-dose shampoos for different hair types.

The brand remains active. Its international site carries a 2026 copyright, its product range continued to expand into the 2020s, and one editorial profile records distribution in more than 60 countries [7]. Ducray sits within Pierre Fabre's dermo-cosmetics portfolio alongside sister brands including Avène, A-Derma, Klorane, René Furterer and MÊME Cosmetics.

The founder, Albert Ducray (born 1901), was the son of a dermatologist and worked as a hairdresser in Belle Époque Paris. According to the Pierre Fabre corporate history, he noticed how the soap powders of the day damaged hair, and in response created a brand under the name Dr Ducray and developed LIK Savon — a range of single-dose shampoos adapted to different hair types [5].

Sources differ slightly on exactly when the brand began. The brand's own history page states that Albert Ducray created the company "between 1929 and 1931" and dates the launch of the LIK range to 1930 [4]. Both Pierre Fabre and editorial coverage use 1930, or the phrase "since 1930," as the brand's founding year [5][7]. The 1930 date is used here, with the 1929–1931 range noted.

Ducray's early growth was tied to the pharmacy channel. From 1957 the company describes itself as a "partner of pharmacies," expanding distribution into a sector that, as one profile puts it, "had never before been interested in the business of cosmetics" [7]. In 1977 its Extra-Gentle shampoo was presented to physicians and, by the brand's account, became the market leader among shampoos sold in pharmacies in France and Europe.

The range broadened from haircare into dermatological skincare over the following decades. Ictyane, a line for dry skin, launched in 1985; Keracnyl, for oily and acne-prone skin, in 1999; and Néoptide, aimed at hair loss in women, in 2009. The brand says it launched more than twenty products through the 1990s. Later milestones include Dexyane Med for eczema in 2016, described as the result of eleven years of research, the Kertyol P.S.O. range for psoriasis-prone skin in 2020, and NEOPTIDE EXPERT in 2022.

Ducray has been part of the Pierre Fabre Group since 1969, when Albert Ducray met the pharmacist Pierre Fabre — whose own laboratories were already investing in hair research — and the brand was acquired [5]. Pierre Fabre, which describes itself as the world's second-largest dermo-cosmetics company, groups Ducray within its dermo-cosmetics and personal-care portfolio alongside brands such as Avène, A-Derma, Klorane, René Furterer and MÊME Cosmetics.

The company frames its work as advanced dermatological science rather than ordinary cosmetics. Its stated commitments are "specialist dermatological products for the skin and scalp," products "prescribed by dermatologists and recommended by pharmacists," and "pioneering science," the last of which also serves as its tagline [3]. In 2010 Ducray adopted what it calls "useful innovation" — designing products meant to improve daily life and provide lasting relief, in the belief that there is always more to be done in treating skin conditions [4]. Across its sites the brand emphasises that it treats diagnosed conditions rather than offering purely cosmetic enhancement.

Ducray's catalogue is organised by skin and scalp concern rather than by ingredient. Long-standing ranges include Anaphase+, Creastim and Néoptide for hair loss; Keracnyl for acne and oily skin; Kelual for cradle cap, dandruff and seborrheic dermatitis; Dexyane for eczema; Melascreen for hyperpigmentation and photo-ageing; and Kertyol P.S.O. for psoriasis. For its Anaphase+ shampoo the company reports that, after six weeks of use, 90% of subjects found it stimulated hair growth and 88% saw a decrease in hair loss [8].

Several of the brand's actives are presented as proprietary. Myrtacine, introduced into the Keracnyl line in 2013, is described by the company as the first patented active ingredient to target C. acnes, the bacteria associated with acne [4]. Anchorane, a patented technology said to increase hair anchorage and stimulate growth, was introduced with NEOPTIDE EXPERT in 2022. Other named ingredients across the range include Celastrol, used for its soothing action.

Ducray's environmental messaging is presented through Pierre Fabre's "Conscious Care" approach. The company states that 97% of its products are made in France and that, since 2019, all of its new product developments have been eco-designed [6]. It has also set targets for 2025: that all new formulas excluding sun care contain over 90% ingredients of natural origin, that 100% of its packaging be made from recycled, recyclable, bio-sourced or compostable materials, and that around 10% of its catalogue move to reusable formats such as bulk and eco-refills.

In a 2020 feature, the Paris magazine O'Bon Paris described Ducray as "an iconic haircare and skincare French brand" and credited it with a "90-year history of medical research and innovation," a range of patents and distribution in over 60 countries [7]. No English-language Wikipedia article exists for the brand, and the available sources record no industry awards.

Ducray is an active brand. As of 2026 its international website is live and carries a current copyright notice [3], its product timeline runs to the 2020s, and it remains in retail distribution across multiple markets. It continues to operate as a dermo-cosmetic brand within the Pierre Fabre Group.